Efficacy of alendronate and risedronate on bone mineral density in men with osteoporosis or osteopenia: a meta-analysis
Class of 2013 Abstract === Specific Aims: To determine efficacy of alendronate (ALN) and risedronate (RIS) for treatment of osteoporosis and osteopenia in men. Methods: Literature search was primarily via PubMed. Inclusion criteria were: randomized controlled trials or observational studies asses...
Main Authors: | Jehle, Karen, Brown, Olivia, Slack, Marion, Lee, Jeannie Kim |
---|---|
Language: | en_US |
Published: |
The University of Arizona.
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/614240 http://arizona.openrepository.com/arizona/handle/10150/614240 |
Similar Items
-
Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
by: Tetsuo Yano, et al.
Published: (2021-06-01) -
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01) -
The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
by: Hüsniye Koç, et al.
Published: (2004-12-01) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01) -
Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
by: Ercan Madenci, et al.
Published: (2003-06-01)